a multicenter , randomized , double-blind assessment of 130 patients with congestive heart failure ( new york heart association functional classes ii to iv ) was undertaken to assess the therapeutic efficacy of lisinopril , an angiotensin-converting enzyme inhibitor .
C0018802
congestive heart failure
C0065374
lisinopril